Skip to main content
AMP 2025 Annual Meeting & Expo Main banner
Final Program


    Lu Wang, MD, PhD

    Associate member
    St. Jude Childrens research hospital
    Memphis, Tennessee, United States

    Lu Wang, MD, PhD, FACMG, is an Associate Member Molecular Pathologist and the Medical Director of Molecular Pathology in the Department of Pathology at St. Jude Children’s Research Hospital (SJCRH). Dr. Wang is a board-certified clinical molecular geneticist and cancer cytogeneticist. She received her MD and PhD degrees in China and completed her post-graduate training at Weill Medical College of Cornell University and Memorial Sloan Kettering Cancer Center (MSKCC) in New York City. Dr. Wang had been a faculty member in the Department of Pathology at MSKCC from 2010 to 2017 and joined the faculty at SJCRH in late 2017. Her clinical-translational research focuses on leukemia genomics/genetics and genomic profiling of rare tumors with an emphasis on clinical translation of potential diagnostic markers and therapeutic targets as well as clinical tests development. Dr. Wang’s lab-based research focuses on addressing further questions in molecular tumorigenesis of recurrent genetic aberrations identified by genome-wide molecular profiling in rare tumors, with a specific focus on functional characterization of oncogenic gene fusions. Dr. Wang also actively collaborate with researchers locally, nationally and internationally, providing molecular genetics/genomics expertise to clinical consultations and to a variety of research projects. Dr. Wang have authored 90+ peer-reviewed original research articles as well as ~20 additional publications including cases reports, invited reviews and commentary and book chapters.

    Disclosure information not submitted.

    Presentation(s):